Webinar: A Potent SARS-CoV-2 Neutralizing Single-domain Antibody (SdAb) Shows Therapeutic Efficacy in the Syrian Golden Hamster Model of COVID-19
Creative Biolabs has invited Dr. James Naismith to walk us through the development process of his novel SARS-CoV-2 neutralising sdAbs and how his team has found a candidate demonstrating promising therapeutic efficacy in a hamster model of COVID-19.
Create your
podcast in
minutes
It is Free